Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL28160239 | 1.00 | THRB (0.52) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL27975714 | 1.00 | THRB (0.52) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL11612221 | 1.00 | THRB (0.52) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL11609903 | 1.00 | THRB (0.52) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL5051653 | 1.00 | THRB (0.52) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL23567287 | 1.00 | THRB (0.52) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL6912038 | 1.00 | THRB (0.52) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL503543 | 1.00 | THRB (0.52) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL5964102 | 1.00 | THRB (0.52) | THRBHTTMEN1KMT2AMAPT | |
| Hexane SCHEMBL28160230 | 1.00 | THRB (0.52) | THRBHTTMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020204662-A1 | DONEPEZIL MYRISTYLOXYMETHYL ETHER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2020-10-08 | — | — | WO | disclosed |
| CN-103657516-B | Ionic liquid surfactant containing ether functional groups and preparation method thereof | UNIV HENAN NORMAL | 2015-02-18 | — | — | CN | disclosed |
| US-8802596-B2 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2014-08-12 | — | — | US | disclosed |
| CN-103271083-A | Multi-functional ionic liquid compositions | UNIV ALABAMA | 2013-09-04 | — | — | CN | disclosed |
| CN-101326275-B | Multifunctional ionic liquid composition | UNIV ALABAMA | 2013-06-05 | — | — | CN | disclosed |
| US-20120264605-A1 | Multi-Functional Ionic Liquid Compositions for Overcoming Polymorphism and Imparting Improved Properties for Active Pharmaceutical, Biological, Nutritional, and Energetic Ingredients | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-10-18 | — | — | US | disclosed |
| US-8232265-B2 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-07-31 | — | — | US | disclosed |
| CN-101326275-A | Multifunctional ionic liquid composition | UNIV ALABAMA (US) | 2008-12-17 | — | — | CN | disclosed |
| EP-1931760-A2 | MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS | The University of Alabama (US) | 2008-06-18 | — | — | EP | disclosed |
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2007-04-26 | — | — | US | disclosed |
| CN-1045626-C | Neutral phosphorus type extracting agent for separating yttrium | SHANGHAI INST ORGANIC CHEM (CN) | 1999-10-13 | — | — | CN | disclosed |
| CN-1220267-A | Bactericide modified quaternary phosphonium salt and preparation method thereof | NANJING CHEMICAL ENGINEERING I (CN) | 1999-06-23 | — | — | CN | disclosed |
| CN-1108309-A | Neutral phosphorus type extracting agent for separating yttrium | SHANGHAI INST ORGANIC CHEM (CN) | 1995-09-13 | — | — | CN | disclosed |
| US-4914091-A | BACTERICIDES | AMERICAN CYANAMID COMPANY (US) | 1990-04-03 | — | — | US | disclosed |
| US-4902710-A | THIO-, SULFINYL-, OR SULFONYL-PROPANAMINES; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS; NERVOUS SYSTEM DISORDERS | ELI LILLY AND COMPANY (US) | 1990-02-20 | — | — | US | disclosed |
| US-4568700-A | NONCARCINOGEN | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1986-02-04 | — | — | US | disclosed |
| EP-0157000-A2 | Ester of cephalosporin derivatives | AMERICAN CYANAMID COMPANY (US) | 1985-10-09 | — | — | EP | disclosed |
| US-4339454-A | ANTICONVULSANTS | COLGATE-PALMOLIVE COMPANY (US) | 1982-07-13 | — | — | US | disclosed |
| US-4249005-A | NON-HYPNOTIC ANTICONVULSIVE | BRISTOL-MYERS COMPANY (US) | 1981-02-03 | — | — | US | disclosed |
| US-4046894-A | Certain barbituric acid derivatives used as anticonvulsant agents | BRISTOL-MYERS COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264605-A1 | Multi-Functional Ionic Liquid Compositions for Overcoming Polymorphism and Imparting Improved Properties for Active Pharmaceutical, Biological, Nutritional, and Energetic Ingredients | SLC5A6, PNLIP, IPMK | THRB 4067/4885HTT 3091/4885MEN1 3114/4885 |
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | SLC5A6, PNLIP, IPMK | THRB 4067/4885HTT 3091/4885MEN1 3114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.